Insider Trading Alert - HNT, MA And GRPN Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Sept. 23, 2014, 39 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $250.00 to $78,529,267.63.

Highlighted Stocks Traded by Insiders:

Health Net (HNT) - FREE Research Report

Yeager Frederick C, who is Director at Health Net, sold 4,000 shares at $47.69 on Sept. 23, 2014. Following this transaction, the Director owned 17,175 shares meaning that the stake was reduced by 18.89% with the 4,000-share transaction.

Tough Steven D, who is Pres, Govt Progrms at Health Net, sold 10,000 shares at $46.90 on Sept. 23, 2014. Following this transaction, the Pres, Govt Progrms owned 95,669 shares meaning that the stake was reduced by 9.46% with the 10,000-share transaction.

The shares most recently traded at $45.81, down $1.09, or 2.38% since the insider transaction. Historical insider transactions for Health Net go as follows:

  • 4-Week # shares sold: 35,473
  • 12-Week # shares sold: 35,473
  • 24-Week # shares sold: 35,473

The average volume for Health Net has been 934,100 shares per day over the past 30 days. Health Net has a market cap of $3.7 billion and is part of the health care sector and health services industry. Shares are up 54.47% year-to-date as of the close of trading on Tuesday.

Health Net, Inc. provides managed health care services through health plans and government-sponsored managed care plans in the United States. It operates through Western Region Operations and Government Contracts segments. The company has a P/E ratio of 15.8. Currently, there are 3 analysts who rate Health Net a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HNT - FREE

TheStreet Quant Ratings rates Health Net as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Health Net Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

MasterCard (MA) - FREE Research Report

MasterCard Foundation, who is 10% Owner at MasterCard, sold 23,679 shares at $76.93 on Sept. 23, 2014. Following this transaction, the 10% Owner owned 118.0 million shares meaning that the stake was reduced by 0.02% with the 23,679-share transaction.

The shares most recently traded at $76.05, down $0.88, or 1.16% since the insider transaction. Historical insider transactions for MasterCard go as follows:

  • 4-Week # shares sold: 99,006
  • 12-Week # shares sold: 398,155
  • 24-Week # shares sold: 447,453

The average volume for MasterCard has been 4.1 million shares per day over the past 30 days. MasterCard has a market cap of $84.9 billion and is part of the financial sector and financial services industry. Shares are down 9.62% year-to-date as of the close of trading on Tuesday.

MasterCard Incorporated provides transaction processing and other payment-related services in the United States and internationally. It facilitates the processing of payment transactions, including authorization, clearing, and settlement, as well as delivers related products and services. The stock currently has a dividend yield of 0.58%. The company has a P/E ratio of 27.5. Currently, there are 17 analysts who rate MasterCard a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MA - FREE

TheStreet Quant Ratings rates MasterCard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full MasterCard Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Groupon (GRPN) - FREE Research Report

Stevens Brian, who is Chief Accounting Officer at Groupon, sold 9,406 shares at $6.92 on Sept. 23, 2014. Following this transaction, the Chief Accounting Officer owned 6,674 shares meaning that the stake was reduced by 58.5% with the 9,406-share transaction.

The shares most recently traded at $6.68, down $0.24, or 3.52% since the insider transaction. Historical insider transactions for Groupon go as follows:

  • 4-Week # shares bought: 16,000
  • 4-Week # shares sold: 9,406
  • 12-Week # shares bought: 16,000
  • 12-Week # shares sold: 9,406
  • 24-Week # shares bought: 16,000
  • 24-Week # shares sold: 31,406

The average volume for Groupon has been 15.5 million shares per day over the past 30 days. Groupon has a market cap of $4.5 billion and is part of the technology sector and internet industry. Shares are down 43.05% year-to-date as of the close of trading on Tuesday.

Groupon, Inc. operates online local commerce marketplaces that connect merchants to consumers by offering goods and services at a discount worldwide. It also offers deals on products for which it acts as the merchant of record. Currently, there are 6 analysts who rate Groupon a buy, 1 analyst rates it a sell, and 12 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GRPN - FREE

TheStreet Quant Ratings rates Groupon as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Groupon Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Dow Sinks for Eighth Straight Session; Intel's CEO Departs -- ICYMI

Dow Sinks for Eighth Straight Session; Intel's CEO Departs -- ICYMI

Dow Logs Eighth Straight Drop as Stocks Slump

Dow Logs Eighth Straight Drop as Stocks Slump

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

U.S. Drillers at Mercy of Iran, Saudi Production Spat as OPEC Meeting Begins

U.S. Drillers at Mercy of Iran, Saudi Production Spat as OPEC Meeting Begins